1. Home
  2. SNY vs IBN Comparison

SNY vs IBN Comparison

Compare SNY & IBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • IBN
  • Stock Information
  • Founded
  • SNY 1994
  • IBN 1955
  • Country
  • SNY France
  • IBN India
  • Employees
  • SNY N/A
  • IBN N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • IBN Commercial Banks
  • Sector
  • SNY Health Care
  • IBN Finance
  • Exchange
  • SNY Nasdaq
  • IBN Nasdaq
  • Market Cap
  • SNY 120.2B
  • IBN 105.0B
  • IPO Year
  • SNY N/A
  • IBN 1999
  • Fundamental
  • Price
  • SNY $47.71
  • IBN $30.30
  • Analyst Decision
  • SNY Buy
  • IBN
  • Analyst Count
  • SNY 2
  • IBN 0
  • Target Price
  • SNY $57.50
  • IBN N/A
  • AVG Volume (30 Days)
  • SNY 2.7M
  • IBN 5.1M
  • Earning Date
  • SNY 01-30-2025
  • IBN 01-21-2025
  • Dividend Yield
  • SNY 4.27%
  • IBN 0.79%
  • EPS Growth
  • SNY N/A
  • IBN 17.31
  • EPS
  • SNY 4.00
  • IBN 0.79
  • Revenue
  • SNY $54,031,898,261.00
  • IBN $19,556,699,818.00
  • Revenue This Year
  • SNY $3.18
  • IBN N/A
  • Revenue Next Year
  • SNY $6.67
  • IBN $13.73
  • P/E Ratio
  • SNY $23.72
  • IBN $18.93
  • Revenue Growth
  • SNY 6.01
  • IBN 24.62
  • 52 Week Low
  • SNY $45.22
  • IBN $23.16
  • 52 Week High
  • SNY $58.97
  • IBN $32.14
  • Technical
  • Relative Strength Index (RSI)
  • SNY 45.07
  • IBN 45.87
  • Support Level
  • SNY $47.01
  • IBN $30.92
  • Resistance Level
  • SNY $49.73
  • IBN $31.51
  • Average True Range (ATR)
  • SNY 0.73
  • IBN 0.41
  • MACD
  • SNY 0.16
  • IBN -0.14
  • Stochastic Oscillator
  • SNY 48.60
  • IBN 19.43

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About IBN ICICI Bank Limited

ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.

Share on Social Networks: